Research

This week’s Research Roundup highlights how fasting blood-glucose levels provide estimate of duration and progression of pancreatic cancer before diagnosis.

This week’s Research Roundup highlights a model for predicting breast cancer risk in women with atypical hyperplasia.

This week’s Research Roundup highlights different mutational rates and mechanisms in human cells at pregastrulation and neurogenesis.

This week’s Research Roundup highlights the clinical and pathological phenotype of genetic causes of focal segmental glomerulosclerosis in adults.

This week’s Research Roundup highlights genetic evidence for early peritoneal spreading in pelvic high-grade serous cancer.

This week’s Research Roundup highlights patterns of homozygosity in patients with uniparental disomy with detection rate and suggested reporting thresholds for SNP microarrays.

This week’s Research Roundup highlights the development of a microscopic colitis disease activity index.

This week’s Research Roundup highlights the analysis of cell-free DNA to assess risk of tumoremia following endoscopic ultrasound fine-needle aspiration of pancreatic adenocarcinomas.

This week’s Research Roundup highlights cardiovascular concerns in BRCA1 and BRCA2 mutation carriers.

This week’s Research Roundup highlights high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology.

This week’s Research Roundup highlights the blast phase myeloproliferative neoplasm with a Mayo-AGIMM study of 410 patients from two separate cohorts.

A recent article in HealthDay News reported on a case of an avid 26-year-old outdoorswoman from Oregon who became the first human ever infected by a type of eye worm previously seen only in cattle. Audrey Schuetz, M.D., Senior Associate Consultant in the Division of Clinical Microbiology in the Department of Laboratory Medicine and Pathology at Mayo Clinic, comments on the eye worm.

This week’s Research Roundup highlights the genomic analysis using regularized regression in high-grade serous ovarian cancer.